Abstract:
PROBLEM TO BE SOLVED: To obtain an antibody excellent in assay accuracy ad useful for diagnostics, kits, vaccines, etc., by setting against hepatitis GB virus(HGBV) epitope(s). SOLUTION: This antibody is such one as to stand against at least one kind of Hepatitis GB virus(HGBV) epitope, being pref. a polyclonal or monoclonal antibody. This antibody is obtained by administering an individual with an isolated immunogenic polypeptide (or a fragment thereof) containing at least one HGBV epitope at an amount enough to induce immune response. Furthermore, it is preferable that a suspectable test sample containing HGBV is contacted with an antibody (fragment) specifically bindable to at least one HGBV antigen for an enough time and under sufficient conditions to form an antibody/antigen complex to detect an antibody-contg. complex to detect a HGBV antigen in the test sample.
Abstract:
PROBLEM TO BE SOLVED: To provide a non-A, non-B, non-C, non-D, non-E type hepatitis reagent, and method for using the same. SOLUTION: The nucleic aid and amino acid sequences of a hepatitis GB virus (HGBV) useful for various diagnoses and treatments, a kit for using the HGBV nucleic acid or amino acid sequence, HGBV-immunogenic particles, an antibody specifically binding with the HGBV, a method for producing a polyclonal antibody or monoclonal antibody from the HGBV nucleic acid or amino acid sequence and a method for detecting a HGBV antigen in a specimen suspected to contain the HGBV are provided. COPYRIGHT: (C)2005,JPO&NCIPI
Abstract:
Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
Abstract:
Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
Abstract:
Hepatitis GB Virus (HGBV) nucleic acid and amino acid sequences useful for a variety of diagnostic and therapeutic applications, kits for using the HGBV nucleic acid or amino acid sequences, HGBV immunogenic particles, and antibodies which specifically bind to HGBV. Also provided are methods for producing antibodies, polyclonal or monoclonal, from the HGBV nucleic acid or amino acid sequences.
Abstract:
The present invention relates to nucleic oligomer primers or probes useful for detection of TTV in test samples. Also provided are assays which utilize these primers and probes, as well as test kits which contain these oligomer primers and/or probes. In addition, the present invention encompasses the use of TTV nucleotide sequences as nucleic acid vectors and as markers for determining transmission between individuals as well as the route thereof. Additionally, the present invention encompasses a method of detecting TTV infection prior to xenotransplantation of a tissue or organ.
Abstract:
Compounds effective in inhibiting replication of Hepatitis C virus ( HCV ) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, coformulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
Abstract:
Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
Abstract:
The present invention relates to nucleic oligomer primers or probes useful for detection of TTV in test samples. Also provided are assays which utilize these primers and probes, as well as test kits which contain these oligomer primers and/or probes. In addition, the present invention encompasses the use of TTV nucleotide sequences as nucleic acid vectors and as markers for determining transmission between individuals as well as the route thereof. Additionally, the present invention encompasses a method of detecting TTV infection prior to xenotransplantation of a tissue or organ.